Base to Base biotech podcast 67: Synthetic DNA and crossing the blood-brain barrier
Base to Base Biotech di Jim Cornall
Note sull'episodio
Times:
02:58 Deep Science Ventures
22:16 4basebio
This week, we have a conversation with Amy Walker, CEO of 4basebio, and Adam Tomassi-Russell, senior director, climate, at Deep Science Ventures.
4basebio
4basebio is a UK-based biotechnology company pioneering the use of synthetic DNA to enable next-generation therapeutics and vaccines.
Through its proprietary enzymatic DNA synthesis platform, 4basebio produces GMP-grade synthetic DNA and mRNA with superior speed, purity, and scalability, overcoming the limitations of plasmid-based systems.
The company offers application-specific DNA constructs tailored to the diverse needs of gene therapies, genome editing, mRNA production, and DNA vaccines, helping partners ...
Parole chiave
biotechbiotechnology4basebioDeep Science Ventures